National lupus hospitalization trends reveal rising rates of herpes zoster and declines in pneumocystis pneumonia

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Murray, Sara G ^a   Schmajuk, Gabriela ^a,b   Trupin, Laura ^a   Gensler, Lianne ^a   Katz, Patricia P ^a,c   Yelin, Edward H ^a,c   Gansky, Stuart A ^c   Yazdany, Jinoos ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Veterans Administration   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTEREMIA; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; ETHNICITY; FEMALE; HERPES ZOSTER; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOSIS; OPPORTUNISTIC INFECTION; OUTCOME ASSESSMENT; PNEUMOCYSTIS PNEUMONIA; RACE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREND STUDY; ADOLESCENT; AGED; COMORBIDITY; CYTOMEGALOVIRUS INFECTIONS; DISEASE PREDISPOSITION; IMMUNOCOMPROMISED PATIENT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; MORBIDITY; MYCOSES; OPPORTUNISTIC INFECTIONS; PNEUMONIA; PNEUMONIA, PNEUMOCYSTIS; PREVALENCE; STATISTICS AND NUMERICAL DATA; TRENDS; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BACTEREMIA; COMORBIDITY; CYTOMEGALOVIRUS INFECTIONS; DISEASE SUSCEPTIBILITY; FEMALE; HERPES ZOSTER; HOSPITALIZATION; HUMANS; IMMUNOCOMPROMISED HOST; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MORBIDITY; MYCOSES; OPPORTUNISTIC INFECTIONS; PNEUMONIA; PNEUMONIA, PNEUMOCYSTIS; PREVALENCE; UNITED STATES; YOUNG ADULT;

EID: 84953897976     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0144918     Document Type: Article

References (45)

1. Barber C, Gold WL, Fortin PR. Infections in the lupus patient: perspectives on prevention: Curr Opin Rheumatol. 2011; 23: 358-365. doi: 10.1097/BOR.0b013e3283476cd8 PMID: 21532484
2. Edwards CJ, Lian TY, Badsha H, Teh CL, Arden N, Chng HH. Hospitalization of individuals with systemic lupus erythematosus: characteristics and predictors of outcome. Lupus. 2003; 12: 672-676. doi: 10.1191/0961203303lu452oa PMID: 14514129
3. Navarro-Zarza JE, Alvarez-Hernández E, Casasola-Vargas JC, Estrada-Castro E, Burgos-Vargas R. Prevalence of community-acquired and nosocomial infections in hospitalized patients with systemic lupus erythematosus. Lupus. 2010; 19: 43-48. doi: 10.1177/0961203309345776 PMID: 19884213
4. Goldblatt F, Chambers S, Rahman A, Isenberg D. Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus. 2009; 18: 682-689. doi: 10.1177/ 0961203308101019 PMID: 19502263
5. Ward MM. Avoidable hospitalizations in patients with systemic lupus erythematosus. Arthritis Care Res. 2008; 59: 162-168. doi: 10.1002/art.23346
6. Ward MM, Donald F. Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum. 1999; 42: 780-789. doi: 10. 1002/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-M PMID: 10211894
7. Chakravarty EF, Michaud K, Katz R, Wolfe F. Increased incidence of herpes zoster among patients with systemic lupus erythematosus. Lupus. 2013; 22: 238-244. doi: 10.1177/0961203312470186 PMID: 23257402
8. Hata A, Kuniyoshi M, Ohkusa Y. Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study. Infection. 2011; 39: 537-544. doi: 10.1007/s15010-011-0162-0 PMID: 21800108
9. Borba EF, Ribeiro ACM, Martin P, Costa LP, Guedes LKN, Bonfá E. Incidence, Risk Factors, and Outcome of Herpes Zoster in Systemic Lupus Erythematosus: JCR J Clin Rheumatol. 2010; 16: 119-122.doi: 10.1097/RHU.0b013e3181d52ed7 PMID: 20216330
10. Tsai WP, Chen MH, Lee MH, Yu KH, Wu MW, Liou LB. Cytomegalovirus infection causes morbidity and mortality in patients with autoimmune diseases, particularly systemic lupus: in a Chinese population in Taiwan. Rheumatol Int. 2012; 32: 2901-2908. doi: 10.1007/s00296-011-2131-4 PMID: 21898057
11. Chen H-H, Chen Y-M, Chen T-J, Lan J-L, Lin C-H, Chen D-Y. Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort. Clinics. 2011; 66: 1177-1182. doi: 10.1590/S1807-59322011000700009 PMID: 21876970
12. Pope JE, Krizova A, Ouimet JM, Goodwin JL, Lankin M. Close association of herpes zoster reactivation and systemic lupus erythematosus (SLE) diagnosis: case-control study of patients with SLE or noninflammatory nusculoskeletal disorders. J Rheumatol. 2004; 31: 274-279. PMID: 14760796
13. Houssiau FA, Vasconcelos C, Cruz D D', Sebastiani GD, Garrido Ed E de R, Danieli MG, et al. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum. 2002; 46: 2121-2131. doi: 10.1002/ art.10461 PMID: 12209517
14. Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med. 2005; 353: 2219-2228. doi: 10.1056/ NEJMoa043731 PMID: 16306519
15. Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, et al. Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis. J Am Soc Nephrol. 2009; 20: 1103-1112. doi: 10.1681/ASN.2008101028 PMID: 19369404
16. Rhee C, Gohil S, Klompas M. Regulatory Mandates for Sepsis Care-Reasons for Caution. N Engl J Med. 2014; 370: 1673-1676. doi: 10.1056/NEJMp1400276 PMID: 24738642
17. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003∗: Crit Care Med. 2007; 35: 1244-1250. doi: 10.1097/01.CCM.0000261890.41311.E9 PMID: 17414736
18. Lagu T, Rothberg MB, Shieh M-S, Pekow PS, Steingrub JS, Lindenauer PK. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007: Crit Care Med. 2012; 40: 754-761. doi: 10.1097/CCM.0b013e318232db65 PMID: 21963582
19. Moores KG, Sathe NA. A systematic review of validated methods for identifying systemic lupus erythematosus (SLE) using administrative or claims data. Vaccine. 2013; 31 Suppl 10: K62-73. doi: 10.1016/ j.vaccine.2013.06.104 PMID: 24331075
20. Schneeweiss S, Robicsek A, Scranton R, Zuckerman D, Solomon DH. Veteran's affairs hospital discharge databases coded serious bacterial infections accurately. J Clin Epidemiol. 2007; 60: 397-409. doi: 10.1016/j.jclinepi.2006.07.011 PMID: 17346615
21. Barber C, Lacaille D, Fortin PR. Systematic Review of Validation Studies of the Use of Administrative Data to Identify Serious Infections. Arthritis Care Res. 2013; 65: 1343-1357. doi: 10.1002/acr.21959
22. Grijalva CG, Chung CP, Stein CM, Gideon PS, Dyer SM, Mitchel EF Jr, et al. Computerized definitions showed high positive predictive values for identifying hospitalizations for congestive heart failure and selected infections in Medicaid enrollees with rheumatoid arthritis. Pharmacoepidemiol Drug Saf. 2008; 17: 890-895. doi: 10.1002/pds.1625 PMID: 18543352
23. Murray SG, Schmajuk G, Trupin L, Lawson E, Cascino M, Barton J, et al. Infection is the leading cause of hospital mortality in patients with dermatomyositis/polymyositis: Data from a population-based study. Arthritis Care Res. 2014; n/a-n/a.
24. McDonald JR, Zeringue AL, Caplan L, Ranganathan P, Xian H, Burroughs TE, et al. Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis Off Publ Infect Dis Soc Am. 2009; 48: 1364-1371. doi: 10.1086/598331
25. Louie GH, Wang Z, Ward MM. Trends in hospitalizations for Pneumocystis jiroveci pneumonia among patients with rheumatoid arthritis in the US: 1996-2007. Arthritis Rheum. 2010; 62: 3826-3827. doi: 10. 1002/art.27735 PMID: 20824796
26. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373-383. PMID: 3558716
27. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi J-C, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005; 43: 1130-1139. PMID: 16224307
28. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Health Care Policy and Research (US); 2006. Available: http://www.ncbi.nlm.nih.gov/books/ NBK52651/
29. Manzi S, Kuller LH, Kutzer J, Pazin GJ, Sinacore J, Medsger TA, et al. Herpes zoster in systemic lupus erythematosus. J Rheumatol. 1995; 22: 1254-1258. PMID: 7562754
30. Rondaan C, de Haan A, Horst G, Hempel JC, van Leer C, Bos NA, et al. Altered Cellular and Humoral Immunity to Varicella-Zoster Virus in Patients With Autoimmune Diseases. Arthritis Rheumatol. 2014; 66: 3122-3128. doi: 10.1002/art.38804 PMID: 25223407
31. Dall'Era M. Mycophenolate mofetil in the treatment of systemic lupus erythematosus: Curr Opin Rheumatol. 2011; 23: 454-458. doi: 10.1097/BOR.0b013e328349a1e5 PMID: 21720247
32. Touma Z, Gladman DD, Urowitz MB, Beyene J, Uleryk EM, Shah PS. Mycophenolate Mofetil for Induction Treatment of Lupus Nephritis: A Systematic Review and Metaanalysis. J Rheumatol. 2011; 38: 69-78. doi: 10.3899/jrheum.100130 PMID: 20952473
33. Mansharamani NG, Garland R, Delaney D, Koziel H. Management and outcome patterns for adult pneumocystis carinii pneumonia, 1985 to 1995∗: Comparison of hiv-associated cases to other immunocompromised states. Chest. 2000; 118: 704-711. doi: 10.1378/chest.118.3.704 PMID: 10988192
34. Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc. 1996; 71: 5-13. PMID: 8538233
35. Gupta D, Zachariah A, Roppelt H, Patel AM, Gruber BL. Prophylactic Antibiotic Usage for Pneumocystis jirovecii Pneumonia in Patients With Systemic Lupus Erythematosus on Cyclophosphamide: A Survey of US Rheumatologists and the Review of Literature. JCR J Clin Rheumatol. 2008; 14: 267-272. doi: 10.1097/RHU.0b013e31817a7e30 PMID: 18679133
36. Houssiau FA, Vasconcelos C, Cruz D D', Sebastiani GD, Garrido E de R, Danieli MG, et al. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis. 2010; 69: 61-64. doi: 10.1136/ard.2008.102533 PMID: 19155235
37. Hahn BH, McMahon M, Wilkinson A, Wallace WD, Daikh DI, FitzGerald J, et al. American College of Rheumatology Guidelines for Screening, Case Definition, Treatment and Management of Lupus Nephritis. Arthritis Care Res. 2012; 64: 797-808. doi: 10.1002/acr.21664
38. Oz HS, Hughes WT. Novel Anti-Pneumocystis carinii Effects of the Immunosuppressant Mycophenolate Mofetil in Contrast to Provocative Effects of Tacrolimus, Sirolimus, and Dexamethasone. J Infect Dis. 1997; 175: 901-904. doi: 10.1086/513988 PMID: 9086147
39. Ritter ML, Pirofski L. Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity. Transpl Infect Dis Off J Transplant Soc. 2009; 11: 290-297. doi: 10. 1111/j.1399-3062.2009.00407.x
40. Husain S, Singh N. The Impact of Novel Immunosuppressive Agents on Infections in Organ Transplant Recipients and the Interactions of These Agents with Antimicrobials. Clin Infect Dis. 2002; 35: 53-61. doi: 10.1086/340867 PMID: 12060875
41. Green H, Paul M, Vidal L, Leibovici L. Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials. Mayo Clin Proc. 2007; 82: 1052-1059. doi: 10.4065/82.9.1052 PMID: 17803871
42. Tektonidou MG, Wang Z, Dasgupta A, Ward MM. Burden of serious infections in adults with systemic lupus erythematosus. A national population-based Study, 1996-2011. Arthritis Care Res. 2015; n/a-n/ a. doi: 10.1002/acr.22575
43. Guthridge JM, Cogman A, Merrill JT, Macwana S, Bean KM, Powe T, et al. Herpes Zoster Vaccination in SLE: A Pilot Study of Immunogenicity. J Rheumatol. 2013; 40: 1875-1880. doi: 10.3899/jrheum. 130170 PMID: 24037550
44. Fishman JA. Infection in Solid-Organ Transplant Recipients. N Engl J Med. 2007; 357: 2601-2614. doi: 10.1056/NEJMra064928 PMID: 18094380
45. Aceves-Avila FJ, Benites-Godínez V. Drug allergies may be more frequent in systemic lupus erythematosus than in rheumatoid arthritis. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis. 2008; 14: 261-263. doi: 10.1097/RHU.0b013e31817a241a